Page 1 | Search Results | Blood | American Society of Hematology

Skip Nav Destination

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Incidence and outcomes of Clostridioides difficile infection in BCMA and CD19 CAR-T cell therapy.

Raj Shah, Fady El Tom, Himil Mahadevia, Nikhil Vojjala, Jad Kassem, Kalan Patel

Blood (2025) 146 (Supplement 1): 7678.

https://doi.org/10.1182/blood-2025-7678

Published: 2025

Journal Articles

Utilization and outcomes of inferior vena cava (IVC) filters in patients with cancer-associated acute venous thromboembolism hospitalizations: Insights from the u.S. national inpatient sample 2018–2022

Fady El Tom, Raj Shah, Jad Kassem, Elie Chalhoub

Blood (2025) 146 (Supplement 1): 3140.

https://doi.org/10.1182/blood-2025-3140

Published: 2025

Journal Articles

Real-world comparison of thrombotic events in patients with Myelodysplastic Syndromes treated with luspatercept versus erythropoietin-stimulating agents using trinetx database

Nikhil Vojjala, Syed Fahad Gillani, Raj Shah, Himil Mahadevia, Charan Vegivinti, Shubham Agrawal, Vijendra Singh

Blood (2025) 146 (Supplement 1): 22.

https://doi.org/10.1182/blood-2025-22

Published: 2025

Journal Articles

Incidence of cytokine release syndrome (CRS), immune effector cell-associated neurotoxicity syndrome (ICANS), infections and cardiovascular events between chimeric antigen receptor (CAR) T-cell therapy products in multiple myeloma (MM): A nationwide analysis

Himil Mahadevia, Karnav Modi, Raj Shah, Shivani Modi, Nikhil Vojjala, Deepthi Vodnala, Taiyeb Khumri, Furha Cossor

Blood (2025) 146 (Supplement 1): 6351.

https://doi.org/10.1182/blood-2025-6351

Published: 2025

Journal Articles

Incidence of cytokine release syndrome (CRS), immune effector cell-associated neurotoxicity syndrome (ICANS), infections and cardiovascular events across different chimeric antigen receptor (CAR) T-cell therapy products in large B-cell lymphoma (DLBCL): A nationwide analysis

Himil Mahadevia, Karnav Modi, Raj Shah, Shivani Modi, Nikhil Vojjala, Taiyeb Khumri, Deepthi Vodnala, Furha Cossor

Blood (2025) 146 (Supplement 1): 8012.

https://doi.org/10.1182/blood-2025-8012

Published: 2025

Journal Articles

Influence of Gender on Outcomes and Palliative Care Utilization in Patients with Hodgkin's Lymphoma: A Retrospective Study Using the National Inpatient Sample Database

Raj Shah, Abdul Rahman Akkawi, Vaibhavi P Mukhtiar, Anas Alqam, Wissam Karam, Joud Zakhour

Blood (2024) 144 (Supplement 1): 6378.

https://doi.org/10.1182/blood-2024-212273

Published: 2024

Journal Articles

Chronic Myeloid Leukemia: Impact of Social and Demographic Disparities on Survival Outcomes

Vaibhavi P Mukhtiar, Om H Gandhi, Charmi Bhanushali, Mansi Mehta, Kush Parikh, Raj Shah, Devang Namjoshi, Fnu Shubhangi, Kala Seetharaman

Blood (2024) 144 (Supplement 1): 534.

https://doi.org/10.1182/blood-2024-210751

Published: 2024

Update search

NARROW

Publications

Format

Article Type

Date

Availability

Incidence and outcomes of Clostridioides difficile infection in BCMA and CD19 CAR-T cell therapy.

Utilization and outcomes of inferior vena cava (IVC) filters in patients with cancer-associated acute venous thromboembolism hospitalizations: Insights from the u.S. national inpatient sample 2018–2022

Real-world comparison of thrombotic events in patients with Myelodysplastic Syndromes treated with luspatercept versus erythropoietin-stimulating agents using trinetx database

Incidence of cytokine release syndrome (CRS), immune effector cell-associated neurotoxicity syndrome (ICANS), infections and cardiovascular events between chimeric antigen receptor (CAR) T-cell therapy products in multiple myeloma (MM): A nationwide analysis

Incidence of cytokine release syndrome (CRS), immune effector cell-associated neurotoxicity syndrome (ICANS), infections and cardiovascular events across different chimeric antigen receptor (CAR) T-cell therapy products in large B-cell lymphoma (DLBCL): A nationwide analysis

Influence of Gender on Outcomes and Palliative Care Utilization in Patients with Hodgkin's Lymphoma: A Retrospective Study Using the National Inpatient Sample Database

Chronic Myeloid Leukemia: Impact of Social and Demographic Disparities on Survival Outcomes

Email alerts

ASH Publications

American Society of Hematology

Update search

Incidence and outcomes of Clostridioides difficile infection in BCMA and CD19 CAR-T cell therapy.

Utilization and outcomes of inferior vena cava (IVC) filters in patients with cancer-associated acute venous thromboembolism hospitalizations: Insights from the u.S. national inpatient sample 2018–2022

Real-world comparison of thrombotic events in patients with Myelodysplastic Syndromes treated with luspatercept versus erythropoietin-stimulating agents using trinetx database

Incidence of cytokine release syndrome (CRS), immune effector cell-associated neurotoxicity syndrome (ICANS), infections and cardiovascular events between chimeric antigen receptor (CAR) T-cell therapy products in multiple myeloma (MM): A nationwide analysis

Incidence of cytokine release syndrome (CRS), immune effector cell-associated neurotoxicity syndrome (ICANS), infections and cardiovascular events across different chimeric antigen receptor (CAR) T-cell therapy products in large B-cell lymphoma (DLBCL): A nationwide analysis

Influence of Gender on Outcomes and Palliative Care Utilization in Patients with Hodgkin's Lymphoma: A Retrospective Study Using the National Inpatient Sample Database

Chronic Myeloid Leukemia: Impact of Social and Demographic Disparities on Survival Outcomes

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only